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Abstract Apoptosis is a physiological form of cell death. Its 
causes and execution mechanisms are not clearly understood. 
Oxidative stress, nitric oxide and its congeners, Ca 2+, proteases, 
nucleases, and mitochondria re considered mediators of apopto- 
sis. At present their importance and exact role are elusive but it 
is clear that mitochondria are both the target and the source of 
oxidative stress, nitric oxide, and Ca 2÷. The mitochondrial mem- 
brane potential (A~b), which is the driving force for mitochondrial 
ATP synthesis, declines during apoptosis, and maintenance of At~ 
prevents apoptosis. Since apoptosis is highly regulated and in- 
volves the activity of hydrolytic enzymes, chromatin condensation 
and vesicle formation apoptosis is likely to have a high energy 
demand. We propose that the cellular ATP level is an important 
determinant for cell death. This hypothesis is supported by cir- 
cumstantial evidence, is consistent with the available data, has a 
corrolary in aging, and is amenable to direct experimental testing 
particularly with flow cytometry as a promising tool. 
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| .  Apoptosis: general considerations - activation vs. execution 
Apoptosis is an evolutionarily conserved form of physiolog- 
ical cell death important for tissue development and homeosta- 
sis. Its hallmarks are distinct morphological terations such as 
nuclear condensation, cell shrinkage, and bleb formation, and 
the absence of inflammatory responses of the affected tissue. 
Deranged apoptosis plays a major role in diseases uch as 
cancer, acquired immune deficiency syndrome, autoimmune 
diseases, and neurodegeneration (reviewed in [1]). 
The program for apoptotic ell death appears to be present 
constitutively in virtually all mammalian cells and can be acti- 
vated by a variety of extra- and intracellular signals. Although 
the various steps and biochemical mechanisms participating in
apoptosis are not completely understood it is clear from genetic 
studies in lower organisms and comparative investigations in
mammalian systems that apoptosis generally comprises four 
distinct stages, namely the decision to die, the execution of 
death, the engulfment of dead cells or fragments thereof, and 
their degradation (reviewed in [2]). 
*Corresponding author. Fax: (41) (1) 632-1121. 
Abbreviations." A~, mitochondrial membrane potential, negative inside; 
NAC, N-acetylcysteine; ROS, reactive oxygen species; TNF-c~, turnout 
necrosis factor-0~. 
2. Mediators of apoptosis 
Several conditions, molecules, or organelles such as oxidative 
stress, Ca 2+, proteases, nucleases, or mitochondria are consid- 
ered participants of apoptosis, but at present it is not always 
clear whether they are required for or are the consequence of
apoptosis. This is due to our incomplete knowledge of the 
cellular machinery and timing of the various stages of apopto- 
sis. Also, studies with reconstituted systems have shown that 
characteristic apoptotic responses occur in isolated nuclei as 
well as in nuclei-free cell fractions. Thus, it is conceivable that 
some of the conditions or molecules are required to direct the 
cell to undergo apoptosis, whereas others may be required for 
its execution. There may also exist cell type-specific require- 
ments. Our understanding of apoptosis i further limited by the 
fact that until recently most studies were done on cell batches, 
i.e. relied on bulk measurements. Unless cells are in perfect 
synchrony, such studies conceivably hide cause/effect relation- 
ships. 
There is ample evidence that apoptosis is accompanied by 
oxidative stress (reviewed in [3]). A valuable tool used to eluci- 
date the importance of oxidative stress is the protooncogen 
bcl-2 (see also below), which stimulates an antioxidative re- 
sponse in cells and prevents apoptosis [4,5]. The importance of 
oxidative stress as a cause for apoptosis was questioned because 
cells can undergo bcl-2-inhibitable apoptosis also under very 
low oxygen tensions [6,7], which supposedly precludes forma- 
tion of reactive oxygen species (ROS). However, 10 nM molec- 
ular oxygen still reacts efficiently in vivo, as revealed in biolu- 
minescence studies with bacteria [8], making the case against 
ROS involvement in apoptosis weaker. 
Also the requirement of Ca 2+ for apoptosis is controversial 
(see [9]). Early reports uggested that a rise of the intracellular 
Ca 2+ leads to apoptosis via endonuclease activation, and more 
recent work indicated that apoptosis is accompanied by shifts 
of Ca 2+ between various intracellular pools. It is worth noting 
that cellular Ca 2+ handling and ROS production are related, 
Thus, increased mitochondrial Ca 2+ release followed by re- 
uptake driven by A~r (Ca 2+ 'cycling') stimulates ROS produc- 
tion (see below). 
Presently, the role of proteases in apoptosis receives much 
attention (reviewed in [10]). Gene analysis in C. elegans identi- 
fied a key pro-apoptotic gene, ced-3, which encodes a putative 
cysteine protease that is related to the mammalian protease 
interleukin-lfl-converting enzyme. Related proteases cleave 
poly(ADPribose) polymerase, which results in the activation of 
a Ca2+/Mg:+-dependent endonuclease implicated in internucle- 
osomal DNA cleavage characteristic for apoptosis. 
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3. Bcl-2 links oxidative stress, Ca 2+, and the mitochondrial mem- 
brane potential to apoptosis 
Given that bcl-2 elicits an antioxidative response in cells, 
what are the biochemical mechanism(s) by which bcl-2 prevents 
apoptosis? We showed [11,12] that one mechanism is the pre- 
vention of ROS-induced mitochondrial Ca 2÷ cycling, a process 
which results in a collapse ofA N and in cellular ATP depletion. 
Thus, bcl-2 prevents disturbances of the cellular Ca 2+ homeo- 
stasis and ROS production at the mitochondrial level. Based 
on these and other findings we suggested [13] that a prooxidant- 
induced Ca 2÷ release from mitochondria, followed by Ca 2÷ 'cy- 
cling' and ATP depletion, is a common cause of apoptosis. 
Accordingly, maintenance of A N stabilises mitochondria nd 
thereby prevents apoptosis. Bcl-2 thus provides the link be- 
tween the antioxidant defense system, Ca 2+, and A N (reviewed 
in [14]). In this context it is interesting to recall that many 
carcinoma cells have an increased AN [15]. 
Another mechanism by which bcl-2 prevents apoptosis could 
relate to a shift of the NADH/NAD + ratio in favour of the 
reduced form: bcl-2 prevents Ca 2+ release from the endoplasmic 
reticulum via the inositol triphosphate-insensitive pathway [16], 
known to be stimulated by NAD+-derived cyclic ADPribose 
(reviewed in [17]). It is conceivable that bcl-2 prevents this 
release by shifting NAD + to NADH, thereby preventing the 
formation of cyclic ADPribose. 
4. Nitric oxide and peroxynitrite in apoptosis 
It was recently shown in several systems that nitric oxide 
(nitrogen monoxide, NO') can cause apoptosis [18-21]. 
NO°-induced apoptosis can be the consequence of DNA 
damage and subsequent expression of the tumor suppressor 
gene p53 [21]. However, according to [22] NO" inhibits apopto- 
sis in lymphocytes. Very recently it was found that also per- 
oxynitrite (ONOO-) induces apoptosis in a time- and concen- 
tration-dependent manner [23], and that depending on the con- 
centration of ONOO- cells die either by apoptosis or necrosis 
[24]. 
5. Mitochondrial Ca 2÷ in cell death 
Attention has been drawn to Ca2+-induced cell death many 
years ago [25]. Excessive intracellular Ca 2+ is thought o con- 
tribute to a final common pathway of cytotoxic events leading 
to ROS formation, necrosis or apoptosis. These events include 
overactivation fprotein kinase C, Ca2+/calmodulin-dependent 
protein kinase II, phospholipases, proteases, protein 
phosphatases, xanthine oxidase, endonucleases, and nitric 
oxide synthase. 
Although the exact role of Ca 2+ in cell killing is unclear, a 
disturbance of mitochondrial Ca 2+ handling can be fatal. The 
normal Ca 2+ 'cycling' across the inner mitochondrial mem- 
brane requires little energy [26]. However, when the Ca 2+ re- 
lease pathway is stimulated by prooxidants, 'cycling' may be- 
come excessive and lead to loss of A N , general leakiness of the 
inner mitochondrial membrane, inhibition of ATP synthesis, 
mitochondrial damage, and cell death (reviewed in [27]). Accor- 
dant with this concept cyclosporine A (CSA), an inhibitor of 
prooxidant-induced Ca 2+ release from mitochondria [28], pro- 
tects against loss of cell viability induced by prooxidants [29] 
or by NO" [30], and favourably alters liver mitochondrial func- 
tions in the postischemic phase at the organ level [31]. 
6. Nitric oxide and the regulation of cytochrome oxidase 
The most-cited and best understood physiological target of 
NO" is guanyl cyclase. NO" stimulates it and thus controls cell 
functions via cGMP, cGMP-gated channels, cGMP-dependent 
protein kinases, and phosphodiesterases. However, NO" also 
binds to cytochrome oxidase and reversibly inhibits mitochon- 
drial respiration by competing with oxygen for this enzyme 
[30,32]. NO" thereby deenergizes mitochondria and nonspecifi- 
cally induces Ca 2+ release from mitochondria. ONOO-, in con- 
trast, induces Ca 2÷ release from mitochondria by activating a
Ca2+-specific pathway (Schweizer and Richter, manuscript sub- 
mitted). Concentrations ofNO" measured in a range of biolog- 
ical systems are similar to those shown to inhibit cytochrome 
oxidase and mitochondrial respiration, and inhibition of NO" 
synthesis results in a stimulation of respiration in many sys- 
tems. It was, therefore, recently proposed that NO" exerts a 
good part of its physiological nd pathological effects on cells 
by inhibiting cytochrome oxidase [33]. 
7. Are mitochondria (or parameters which they control) essential 
for apoptosis? If yes, which mitochondrial parameters? 
As mentioned above, ROS and Ca 2+, two entities presumably 
important for apoptosis, are linked to mitochondria. These two 
entities are under certain conditions even directly related: ROS 
stimulate a specific Ca 2+ release from mitochondria, nd when 
mitochondria 'cycle' Ca 2+ excessively their ROS production 
increases [11,34,35]. Accordingly, tumour necrosis factor-~ 
(TN F-s) stimulates ROS production by mitochondria, nd the 
TNF-~-induced apoptotic killing of at least some cell types is due 
to ROS-induced mitochondrial Ca 2÷ cycling since apoptosis is 
prevented by mitochondrial Ca 2+ uptake inhibitors [11,12]. 
The suspected requirement of mitochondria for apoptosis 
was directly investigated by two groups. In one study cells 
harbouring respiratory chain-deficient (p0) mitochondria were 
capable of apoptosis and it was concluded that mitochondrial 
respiration is not required for it [36]. However, it should be 
remembered that such cells very likely up-regulate glycolysis 
and have high ATP levels, as indicated by the findings [37-39] 
that their mitochondria maintain a high A N, presumably gener- 
ated by intramitochondrial ATP hydrolysis [39]. The other 
study used isolated nuclei in combination with various cell 
fractions [40]. In this reconstituted system, which is believed to 
be a valid model for apoptosis, mitochondria were indeed re- 
quired for apoptosis. The exact function of mitochondria was, 
however, not established and it was postulated that they may 
produce a hitherto unidentified factor necessary for apoptosis. 
A clue as to which mitochondrial parameter(s) may be im- 
portant for the control of apoptosis comes from the observa- 
tion that the stabilisation of AN either by overexpression of
bcl-2 or by the ionophor nigericin, prevents apoptosis induced 
by TNF-~ [12]. 
8. Hypothesis: ATP levels as gauge, or mitochondria s the 
central switchboard for apoptosis 
There is general agreement that apoptosis is an active, 
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energy-requiring process. We propose that the cellular ATP 
level is an important determinant for cell death, either by apop- 
tosis or necrosis. This hypothesis  supported by circumstantial 
evidence, isconsistent with most available data, has a corrolary 
in aging, and is amenable to direct experimental testing. We 
argue that a cell stays alive as long as a certain ATP level is 
maintained. When ATP falls below this level apoptosis ensues 
provided enough ATP is still available for energy-requiring 
apoptotic processes such as enzymatic hydrolysis ofmacromol- 
ecules, nuclear condensation a d bleb formation. Only when 
there is a severe drop in cellular ATP controlled cell death 
ceases and ushers in necrosis. 
A decreased cellular ATP level is characteristic for cell death, 
but there is no systematic nvestigation whether the decrease is
the cause or the consequence of cell death. However, it has been 
shown with six human and murine leukemia/lymphoma cell
lines [41] that the expression of the bcl-2 gene and the cellular 
energy status are highly correlated, and that both parameters 
are inversely related to the sensitivity for glucocorticoid-in- 
duced apoptosis. An ADP/ATP ratio of about 0.2 was the 
critical discriminator between survival and apoptosis in all cell 
types. Also, acute inhibition of the mitochondrial respiratory 
chain induces apoptosis in cells carrying normal mitochondria, 
but not in p0 cells, which maintain their ATP levels by glycolysis 
[42]. This was taken as support for the argument that active 
mitochondria are required for apoptosis, and it was suggested 
that cells with impaired mitochondrial energy metabolism 
reach an energy threshold which triggers apoptosis. It was 
similarly argued that aging and age-related diseases are caused 
by a fall of the energy charge below a threshold (reviewed in 
[43]). 
A critical evaluation whether mitochondria, nd which mito- 
chondrial parameter(s), are important for apoptosis could 
come from the analysis of apoptosis, AN, mitochondrial Ca 2+ 
handling, ROS production, and the cellular ATP level at the 
single cell level and in selected cell populations. 
9. New perspectives: single cell measurements 
In the last years, flow cytometry contributed greatly to the 
understanding of apoptosis. In particular, it became possible to 
determine at the single cell level morphological, biochemical, 
metabolic and phenotypical changes [44] including those re- 
garding physical modifications of the cell (forward and side 
scattering), DNA content [45], stainability [46], and strand 
breaks [47], plasma membrane fluidity [48], pbospholipids [49], 
intracellular pH [50], the activity of the ATP-dependent lyso- 
somal proton pump [51], and cytoskeleton [52]. 
A growing attention is now devoted to mitochondrial func- 
tions during apoptosis. Using the mitochondria-specific probe 
JC-1 we developed a cytofluorimetric technique to study A N in 
intact cells [53] or in single isolated mitochondria [54], which 
was applied to rat thymocytes undergoing dexamethasone-in- 
duced apoptosis. AN is preserved in its early phases [55], and 
decreases after the onset of DNA alterations, assessed by aga- 
rose gel electrophoresis and detection of the DNA content with 
flow cytometry. A similar, delayed ecrease in A N was observed 
in other models of apoptosis, such as that induced by Sendai 
virus or Herpes virus type I [56] or by 2-deoxy-D-ribose in 
human lymphocytes [57,58]. In a more rapid model of apopto- 
sis, i.e. that induced by TNF-~ in cycloheximide-treated U937 
cells [44], the percentage ofapoptotic cells 4 h after the addition 
of TNF-c~ was similar to that of cells with depolarized mito- 
chondria. N-Acetylcysteine (NAC) protected cells against ap- 
optosis and prevented AN decrease, suggesting a direct effect 
of NAC on mitochondria. A protective ffect of NAC on both 
apoptosis and A N was also observed in human lymphocytes 
treated with 2-deoxy-D-ribose [58]. Our data indicate that mito- 
chondria play a complex role during the different phases of 
apoptosis. Indeed, their functional integrity appears to be im- 
portant during the early phases, where a variety of energy- 
requiring intracellular p ocesses occurs. Later on, a functional 
impairment of mitochondria follows, which likely contributes 
to the drop of ATP observed when apoptosis has progressed. 
At variance with our results, A N decrease prior to DNA 
damage was reported by others [59,60]. These discrepancies 
could be due to the dye used, i.e. DiOC6(3), which binds to 
intracellular membranes other than mitochondria, including 
the endoplasmic reticulum [61], and is probably an indicator of 
the 'cytoplasmic membrane potential' [62]. 
Alterations of the cellular energy charge may play a major 
role in the decision of the cell to die by apoptosis or necrosis. 
In this context, analysis of ATP at the single cell level by sorting 
cells with different AN will be of crucial importance. Single cell 
measurements ofA N and ATE applied to the study of apopto- 
sis induced by various stimuli, can help to understand the in- 
triguing relationship between mitochondrial functions and ap- 
optosis. 
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